 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE--Kezar Life Sciences, Inc. Nasdaq: KZR, a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that three posters will be presented at the upcoming American College of Rheumatology ACR Convergence 2022, which will take place November 10 14, 2022 in Philadelphia, PA. Of note, the Phase 2 MISSION poster will include the full data set from the concluded 